Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer’s Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer’s Therapeuticsmarket, defines the market attractiveness level of Alzheimer’s Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer’s Therapeutics industry, describes the types of Alzheimer’s Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer’s Therapeutics market and the development prospects and opportunities of Alzheimer’s Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer’s Therapeutics market in Chapter 13.
By Player:
Daiichi Sankyo Company Ltd
Novartis AG
Eli Lilly And Company
Teva Pharmaceuticals Industries Ltd
H Lundbeck A/S
VTV Therapeutics
AC Immune
Janssen Pharmaceutical
Pfizer, Inc
Actavis plc
TauRx Pharmaceuticals Ltd
Hoffman-La Roche Ltd
GE healthcare
DiaGenic ASA
Merck & Co Inc
Forest Laboratories
Eisai Co Ltd
AstraZeneca
By Type:
Donepezil
Memantine
Rivastigmine
By End-User:
Hospital Pharmacies
Retail Pharmacies
E-commerce
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer’s Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer’s Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer’s Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer’s Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer’s Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.2 United States Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.3 Europe Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.4 China Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.5 Japan Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.6 India Alzheimer’s Therapeutics Consumption (2017-2022)
-
7.7 South Korea Alzheimer’s Therapeutics Consumption (2017-2022)
8 Region and Country-wise Alzheimer’s Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer’s Therapeutics Consumption Forecast (2022-2028)
9 Global Alzheimer’s Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer’s Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Donepezil Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Memantine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer’s Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global E-commerce Consumption and Growth Rate (2017-2022)
10 Global Alzheimer’s Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer’s Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Donepezil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Memantine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer’s Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global E-commerce Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer’s Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer’s Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer’s Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer’s Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer’s Therapeutics Market Competitive Analysis
-
14.1 Daiichi Sankyo Company Ltd
-
14.1.1 Daiichi Sankyo Company Ltd Company Details
-
14.1.2 Daiichi Sankyo Company Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Daiichi Sankyo Company Ltd Alzheimer’s Therapeutics Product and Service
-
14.2 Novartis AG
-
14.2.1 Novartis AG Company Details
-
14.2.2 Novartis AG Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis AG Alzheimer’s Therapeutics Product and Service
-
14.3 Eli Lilly And Company
-
14.3.1 Eli Lilly And Company Company Details
-
14.3.2 Eli Lilly And Company Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly And Company Alzheimer’s Therapeutics Product and Service
-
14.4 Teva Pharmaceuticals Industries Ltd
-
14.4.1 Teva Pharmaceuticals Industries Ltd Company Details
-
14.4.2 Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Product and Service
-
14.5 H Lundbeck A/S
-
14.5.1 H Lundbeck A/S Company Details
-
14.5.2 H Lundbeck A/S Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 H Lundbeck A/S Alzheimer’s Therapeutics Product and Service
-
14.6 VTV Therapeutics
-
14.6.1 VTV Therapeutics Company Details
-
14.6.2 VTV Therapeutics Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 VTV Therapeutics Alzheimer’s Therapeutics Product and Service
-
14.7 AC Immune
-
14.7.1 AC Immune Company Details
-
14.7.2 AC Immune Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AC Immune Alzheimer’s Therapeutics Product and Service
-
14.8 Janssen Pharmaceutical
-
14.8.1 Janssen Pharmaceutical Company Details
-
14.8.2 Janssen Pharmaceutical Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Janssen Pharmaceutical Alzheimer’s Therapeutics Product and Service
-
14.9 Pfizer, Inc
-
14.9.1 Pfizer, Inc Company Details
-
14.9.2 Pfizer, Inc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Pfizer, Inc Alzheimer’s Therapeutics Product and Service
-
14.10 Actavis plc
-
14.10.1 Actavis plc Company Details
-
14.10.2 Actavis plc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Actavis plc Alzheimer’s Therapeutics Product and Service
-
14.11 TauRx Pharmaceuticals Ltd
-
14.11.1 TauRx Pharmaceuticals Ltd Company Details
-
14.11.2 TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Product and Service
-
14.12 Hoffman-La Roche Ltd
-
14.12.1 Hoffman-La Roche Ltd Company Details
-
14.12.2 Hoffman-La Roche Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Hoffman-La Roche Ltd Alzheimer’s Therapeutics Product and Service
-
14.13 GE healthcare
-
14.13.1 GE healthcare Company Details
-
14.13.2 GE healthcare Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 GE healthcare Alzheimer’s Therapeutics Product and Service
-
14.14 DiaGenic ASA
-
14.14.1 DiaGenic ASA Company Details
-
14.14.2 DiaGenic ASA Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 DiaGenic ASA Alzheimer’s Therapeutics Product and Service
-
14.15 Merck & Co Inc
-
14.15.1 Merck & Co Inc Company Details
-
14.15.2 Merck & Co Inc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Merck & Co Inc Alzheimer’s Therapeutics Product and Service
-
14.16 Forest Laboratories
-
14.16.1 Forest Laboratories Company Details
-
14.16.2 Forest Laboratories Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Forest Laboratories Alzheimer’s Therapeutics Product and Service
-
14.17 Eisai Co Ltd
-
14.17.1 Eisai Co Ltd Company Details
-
14.17.2 Eisai Co Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Eisai Co Ltd Alzheimer’s Therapeutics Product and Service
-
14.18 AstraZeneca
-
14.18.1 AstraZeneca Company Details
-
14.18.2 AstraZeneca Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 AstraZeneca Alzheimer’s Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer’s Therapeutics
-
Figure Alzheimer’s Therapeutics Picture
-
Table Global Alzheimer’s Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer’s Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer’s Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer’s Therapeutics Consumption by Country (2017-2022)
-
Figure United States Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer’s Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer’s Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer’s Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Donepezil Consumption and Growth Rate (2017-2022)
-
Figure Global Memantine Consumption and Growth Rate (2017-2022)
-
Figure Global Rivastigmine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global E-commerce Consumption and Growth Rate (2017-2022)
-
Figure Global Donepezil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Memantine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rivastigmine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-commerce Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer’s Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer’s Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Daiichi Sankyo Company Ltd (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Company Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Company Ltd Alzheimer’s Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Alzheimer’s Therapeutics Product and Service
-
Table Eli Lilly And Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly And Company Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly And Company Alzheimer’s Therapeutics Product and Service
-
Table Teva Pharmaceuticals Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Industries Ltd Alzheimer’s Therapeutics Product and Service
-
Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck A/S Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck A/S Alzheimer’s Therapeutics Product and Service
-
Table VTV Therapeutics (Foundation Year, Company Profile and etc.)
-
Table VTV Therapeutics Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table VTV Therapeutics Alzheimer’s Therapeutics Product and Service
-
Table AC Immune (Foundation Year, Company Profile and etc.)
-
Table AC Immune Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AC Immune Alzheimer’s Therapeutics Product and Service
-
Table Janssen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceutical Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceutical Alzheimer’s Therapeutics Product and Service
-
Table Pfizer, Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc Alzheimer’s Therapeutics Product and Service
-
Table Actavis plc (Foundation Year, Company Profile and etc.)
-
Table Actavis plc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis plc Alzheimer’s Therapeutics Product and Service
-
Table TauRx Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table TauRx Pharmaceuticals Ltd Alzheimer’s Therapeutics Product and Service
-
Table Hoffman-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table Hoffman-La Roche Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffman-La Roche Ltd Alzheimer’s Therapeutics Product and Service
-
Table GE healthcare (Foundation Year, Company Profile and etc.)
-
Table GE healthcare Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE healthcare Alzheimer’s Therapeutics Product and Service
-
Table DiaGenic ASA (Foundation Year, Company Profile and etc.)
-
Table DiaGenic ASA Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table DiaGenic ASA Alzheimer’s Therapeutics Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Alzheimer’s Therapeutics Product and Service
-
Table Forest Laboratories (Foundation Year, Company Profile and etc.)
-
Table Forest Laboratories Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Forest Laboratories Alzheimer’s Therapeutics Product and Service
-
Table Eisai Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Eisai Co Ltd Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Co Ltd Alzheimer’s Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Alzheimer’s Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Alzheimer’s Therapeutics Product and Service
-
